ATAI Life Sciences N.V (NASDAQ:ATAI) price on Wednesday, December 04, fall -1.84% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $1.60.
A look at the stock’s price movement, the close in the last trading session was $1.63, moving within a range at $1.53 and $1.685. Turning to its 52-week performance, $2.85 and $1.03 were the 52-week high and 52-week low respectively. Overall, ATAI moved 48.15% over the past month.
ATAI Life Sciences N.V’s market cap currently stands at around $268.49 million, with investors looking forward to this quarter’s earnings report slated for in January.
The average forecast suggests up to a 1,288.89% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 554.33k, representing a 159.03% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that ATAI is a 100% Buy. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in 50% Buy category.
1 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 1 recommend ATAI as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
ATAI’s current price about 2.47% and 22.12% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 55.54, while 7-day volatility ratio is 6.65% and 12.79% in the 30-day chart. Further, ATAI Life Sciences N.V (ATAI) has a beta value of 1.13, and an average true range (ATR) of 0.15. Analysts have given the company’s stock an average 52-week price target of $6, forecast between a low of $6 and high of $6. Looking at the price targets, the low is -275.0% off current price level while to achieve the yearly target high, price needs to move -275.0%. Nonetheless, investors will most likely welcome a -275.0% jump to $6 which is the analysts’ median price.
If we refocus on ATAI Life Sciences N.V (NASDAQ:ATAI), historical trading data shows that trading volumes averaged 1.52 over the past 10 days and 1.16 million over the past 3 months. The company’s latest data on shares outstanding shows there are 167.82 million shares.
The 30.24% of ATAI Life Sciences N.V’s shares are in the hands of company insiders while institutional holders own 7.14% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 9.87 million on 2024-11-15, giving us a short ratio of 6.3. The data shows that as of 2024-11-15 short interest in ATAI Life Sciences N.V (ATAI) stood at 771.0 of shares outstanding, with shares short rising to 9.59 million registered in 2024-10-15. Current price change has pushed the stock 13.48% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the ATAI stock continues to rise going into the next quarter.
